caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952391716

Homam AlkaiedMD

Hematology-OncologyDuluth, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Homam Alkaied's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 14 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Anne Silva-Benedict
Hematology-Oncology · Duluth, MN
35228
Mikhail Perlov
Hematology-Oncology · Seattle, WA
30196
Naveen Gowda
Diagnostic Radiology · Minneapolis, MN
29178
Steven Bonin
Radiation Oncology · Duluth, MN
271,318
Jon Steinhauer
Pathology · Lincoln, NE
26145
Sarah Lundeen
Pathology · Duluth, MN
19158
Steven Eastep
Pathology · Duluth, MN
16104
LAKE VIEW MEMORIAL HOSPITAL, INCORPORATED16219
Disha Mookherjee
Cardiology · Duluth, MN
1554
SMDC MEDICAL CENTER1237
James Mohn
Cardiology · Duluth, MN
1151
Laszlo Tekler
Cardiology · Duluth, MN
1158
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
220
Unique beneficiaries
—
Total services
413
Distinct HCPCS
4
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 189 Hematology-Oncology providers in MN — above median (cohort median 389).
PRESCRIBING · PART D · 2024
Total Rx claims
1,263
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
43
Brand share
20.7%
Top prescribed drugs
Anastrozole160 claims
Potassium Chloride86 claims
Tamoxifen Citrate66 claims
Prochlorperazine Maleate64 claims
Acyclovir55 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.